EUVIMEDEUVIMED entdecken
Open Access

Proteogenomic Discovery of Novel Open Reading Frames With HLA Immune Presentation on Human β-Cells

Kathryn Walters, Roberto Castro-Gutierrez, Soumyadeep Sarkar, Amber Baldwin, Alexandra S Baker, Ali H Shilleh, Amanda M Anderson, Maki Nakayama, Tim Fugman, Ernesto S Nakayasu, Neelanjan Mukherjee iD, Holger A Russ iD

Diabetes · 2025

DOI: 10.2337/db24-0527 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes, 2025. Verfasst von Kathryn Walters und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Genetics, University of Colorado Anschutz Medical Campus, Aurora, CO. Hauptthemen laut MEDLINE: Insulin-Secreting Cells, Proteogenomics, Open Reading Frames, Antigen Presentation. Die Arbeit nennt 60 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NIDDK/HIRN, Juvenile Diabetes Research Foundation (JDRF).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ribosome profiling (Ribo-seq) measures translational regulation and reveals novel or unannotated open reading frames (nuORFs) otherwise difficult to identify. Recent reports demonstrate that nuORFs regulate gene expression and immune recognition, highlighting their emerging biological roles. Pancreatic β-cells are critical for maintaining euglycemic conditions, and β-cell impairment contributes to diabetes development. Identification of nuORF and protein/peptide products in human β-cells could reveal novel mechanisms that regulate β-cell function during homeostatic and disease conditions. Here, we applied a proteogenomic approach to human β-cells to define previously unknown protein/peptide products. First, we applied cell type–specific Ribo-seq to map the translatome of human stem cell–derived β-cells (sBCs). Pathways crucial for β-cell function and antigen presentation were subject to translational regulation. We detected a recently described immunogenic neoantigen, INS-DRiP, presumably originating from a downstream start site in INS mRNA. Moreover, our analysis revealed 965 novel nuORFs in sBCs, with a majority showing protein-level support. Comparison with primary human islets further validated nuORF translation and highlighted β-cell specificity. We identified a novel, primate-specific regulatory upstream ORF within TYK2, which is crucial for β-cell function and interferon response and has many variants strongly associated with type 1 diabetes. Finally, we used immunopeptidomics, HLA-binding prediction models, and T-cell coculture assays to validate the presentation and immunogenicity of preproinsulin peptides and nuORFs. Our findings underscore the importance of translational regulation in β-cell function and provide an important resource to the diabetes research community. Article Highlights We developed a cell type–specific proteogenomic approach to reveal novel or unannotated open reading frames (nuORFs) using transcriptomics, ribosomal profiling, and proteomic analysis of human pancreatic β-cells using stem cell–derived β-cells and/or cadaveric islets. Our analysis revealed translational regulation of β-cell–specific pathways during differentiation and identified 965 nuORFs, with a majority exhibiting protein support and substantial β-cell specificity. A primate-specific ORF located in the 5′ untranslated region of the type 1 diabetes risk gene TYK2 may act as a translational activator. We provide HLA class I immunopeptidomic data from cytokine-stimulated human β-cells and demonstrate their utility in coculture assays with autoreactive T-cell transductants. Taken together, our results define the human β-cell translatome, an important resource to the research field.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Insulin-Secreting CellsProteogenomicsOpen Reading FramesAntigen PresentationHLA AntigensHumans

Substanzen

HLA Antigens

Autor:innen und Institutionen

  • Department of Biochemistry and Molecular Genetics, University of Colorado Anschutz Medical Campus, Aurora, CO.
  • RNA Bioscience Initiative, University of Colorado Anschutz Medical Campus, Aurora, CO.
  • Barbara Davis Center for Diabetes, University of Colorado Anschutz Medical Campus, Aurora, CO.
  • Diabetes Institute, University of Florida, Gainesville, FL.
  • Department of Pharmacology and Therapeutics, College of Medicine, University of Florida, Gainesville, FL.
  • Biological Sciences Division, Pacific Northwest National Laboratory, Richland, WA.

ORCID-Profile: Neelanjan Mukherjee, Holger A Russ

Förderung

  • NIDDK NIH HHS
  • NIDDK/HIRN
  • Juvenile Diabetes Research Foundation (JDRF)
  • Endocrine Society
  • National Science Foundation Graduate Research Fellowship
  • NIGMS NIH HHS
  • NIH HHS
  • NINDS NIH HHS

Zitieren

APA

Walters, K., Castro-Gutierrez, R., Sarkar, S., Baldwin, A., Baker, A. S., Shilleh, A. H., Anderson, A. M., Nakayama, M., Fugman, T., Nakayasu, E. S., Mukherjee, N., & Russ, H. A. (2025). Proteogenomic Discovery of Novel Open Reading Frames With HLA Immune Presentation on Human β-Cells. Diabetes. https://doi.org/10.2337/db24-0527

Vancouver

Walters K, Castro-Gutierrez R, Sarkar S, Baldwin A, Baker AS, Shilleh AH, et al. Proteogenomic Discovery of Novel Open Reading Frames With HLA Immune Presentation on Human β-Cells. Diabetes. 2025. doi:10.2337/db24-0527

BibTeX
@article{Walters2025,
  author = {Walters, Kathryn and Castro-Gutierrez, Roberto and Sarkar, Soumyadeep and Baldwin, Amber and Baker, Alexandra S and Shilleh, Ali H and Anderson, Amanda M and Nakayama, Maki and Fugman, Tim and Nakayasu, Ernesto S and Mukherjee, Neelanjan and Russ, Holger A},
  title = {Proteogenomic Discovery of Novel Open Reading Frames With HLA Immune Presentation on Human β-Cells},
  journal = {Diabetes},
  year = {2025},
  doi = {10.2337/db24-0527}
}
Kostenlos starten →